<DOC>
	<DOCNO>NCT03076918</DOCNO>
	<brief_summary>This study compare efficacy tolerance new device ( FLEXITHERALIGHT ) photodynamic therapy treatment keratosis actinic comparison classical PDT Aktilite® .</brief_summary>
	<brief_title>Evaluating Device FLEXITHERALIGHT Compared Conventional Photodynamic Therapy</brief_title>
	<detailed_description>The study intraindividual comparison two method . The number subject enrolled 47 patient . All participant receive two treatment single visit : first period 2.5 hour illumination FLEXITHERALIGHT device follow continuous red light Spectrum ( 7 10 minute ) Aktilite® appropriate incubation methyl aminolevulinate ) . Patients complete pain assessment scale receiving treatment , , 3 follow visit schedule .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Clinical diagnosis minimum 10 previously untreated pigment , nonhyperkeratotic AK lesion Grade I II forehead and/or scalp ( accord Olsen et Al . JAAD 1991 , cf . REF 31 ) therapy unacceptable consider medically less appropriate symmetrical repartition side forehead and/or scalp . The diagnosis AK determine upon clinical evaluation ( i.e . visual inspection palpation ) investigator . Symmetrical area term number severity lesion . The axis symmetry two area define investigator accord distribution lesion . The two area treat coalesce . A minimum distance 10mm required lesion locate 2 symmetrical area . A minimum distance 2 mm require lesion side . Minimum 5 lesion similar dimension symmetrical area treat . If number lesion &gt; 7 , 7 lesion side consider . Patients porphyria . Patients immunosuppressed idiopathic , disease specific therapeutic reason . Use topical corticosteroid lesional area within 2 week PDT . Patients receive local treatment ( include cryotherapy curettage , Patients receive topical treatment ( include imiquimod , 5FU diclofenac , Picato ) face / scalp area within last 3 month . Use topical retinoids alphahydroxy acid , urea systemic retinoids , chemotherapy immunotherapy within 4 week PDT . Pigmented AK lesion ( ) . Known allergy Metvixia , similar PDT compound excipients cream include arachis oil , peanut soya . Participation clinical study either currently within last 30 day . Female subject must either : Nonchildbearing potential , i.e . postmenopausal confirm clinical history sterility ( e.g . subject without uterus ) , Childbearing potential , provide confirm negative urine pregnancy test prior study treatment , rule pregnancy . Any condition may associate risk poor protocol compliance . Patients currently receive regular ultraviolet radiation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PDT , Methyl Aminolevulinate , Light Emitting Textile</keyword>
</DOC>